Osteonecrosis of the jaw - an update (FT2614)

AvailabilityCourse has taken place
SubjectOral and maxillofacial surgery
DescriptionVinod graduated with honours from Liverpool University in 2007. He then went on to do VT and subsequently a series of SHO jobs in OMFS, head and neck surgery and dental. This was followed by specialist training in Oral Surgery at Guys Dental Hospital obtaining his Royal College membership exam and CCST in December 2013. He then continued in the department as an associate specialist and since June 2016, to date works as a consultant oral surgeon at Guys.
VenueMain Room, Center Parcs Longleat Forest, Warminster - Swindon & N Wiltshire  View details
Date & timeThursday 14 February 2019, 15:00 to 17:00
LecturerDr Vinod Patel  View details
Target audience

Recommended to all

Development outcomeC
Course styleLecture
Catering Tea and coffee only
Core topic Not a core topic
CPD hours2:00
CostNo charge
Aims

To update delegates on bisphosphonates, new anti-resorptive bone agents and anti-angiogenic medications, their mechanisms of action and indication for prescription

Objectives

To be aware of the clinical presentation, signs and symptoms of a medication related osteonecrosis of the jaw (MRONJ)

To be aware of diagnosis and management of patients with an MRONJ and when to refer

To be aware of assessing patient risk of an MRONJ and alternative treatment strategies in the prevention of MRONJ

To be able to manage patients on bisphosphonates and other bone anti-resorptive medications

to be able to ascertain when to refer patients for surgical treatment and when treatment is appropriate in primary dental care

To be able to diagnose and osteonecrosis and prepare the patient for anticipated management upon referral

To be able to prevent any procedures with may induce an osteonecrosis

Learning outcomes

For delegates to know what the risks for medication-related osteonecrosis of the jaw (MRONJ) are, how to manage the risks, and when to refer to secondary care. Delegates will also gain an understanding of the secondary care management of these patients.